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Background:  The objective of this NASA Short-Duration Bioastronautics Investigation (SDBI) 
was to assess spaceflight-associated immune dysregulation.   Many previous studies have 
investigated this phenomenon post-flight, and found altered distribution and function of the 
peripheral leukocyte populations.  Alterations in cytokine production profiles have also been 
reported.  Unfortunately, post-flight data may be altered by the stress associated with high-G 
re-entry and readaptation to unit gravity following deconditioning.  Therefore, the current study 
collected blood and saliva samples from crewmembers immediately before landing, and 
returned those samples to Earth for terrestrial analysis.   Assays include peripheral 
comprehensive immunophenotype, T cell function, cytokine profiles, viral-specific immunity, 
latent viral reactivation (EBV, CMV, VZV), and stress hormone measurements.  A total of 18 
short duration crewmembers completed the study and the final data will be presented. 
 
General Immune Status:  The constitutive distribution of most peripheral leukocyte subset 
populations is largely unaltered during flight.   Exceptions include a mild increase in levels of 
memory CD4+ T cells, and a decrease in naïve CD8+ T cells accompanied by a corresponding 
increase in central/effector memory CD8+ T cells.   No increase in constitutively activated T 
cells was observed during flight.   Various functional measurements were employed.   Cytokine 
producing T cells (intracellular measurement; both CD4+/IL-2+ and CD8+/IFNg+) were mildly 
reduced during flight and further reduced upon landing.  General T cell function (early 
blastogenesis response to mitogenic stimulation), yielded varying results.   T cell stimulation 
with Staphyloccoal enterotoxins was dramatically reduced in-flight, whereas T cell stimulation 
with anti-TCR antibodies was unchanged in-flight 
(and elevated post-flight).   The post-flight elevation 
is in concurrence with previously published findings 
for that mitogen.  Bulk secreted Th1/Th2 cytokines 
were measured following T cell activation, and 
mitogen-dependant in-flight reductions were 
observed in IFNg, IL-10, TNFa and IL-6 production.  
Secreted inflammatory cytokines levels were also 
measured following monocyte stimulation (LPS), 
however a fight-associated decrease was only 
observed for IL-10, whereas IL-8 levels were 
increased during flight.  
 
Viral Specific Immunity:  The number of virus-specific CD8+ T-cells was measured using MHC 
tetramers, while their function was measured using intracellular cytokine analysis following 
peptide stimulation. Both the number and function of EBV-specific cells decreased during flight 
as compared to preflight levels. The number of CMV-specific T-cells generally increased as the 
mission progressed while their function was generally unaltered.  Viral (EBV) load in blood was 
elevated postflight. Elevated anti-EBV VCA antibodies were evident in ~40% of the astronauts; 
anti-CMV antibodies generally increased during and after flight.  
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Latent viral reactivation:  Samples collected from crewmembers before, during and after space 
flight were analyzed by the real time polymerase chain reaction (PCR) for the presence of 
virus. Epstein-Barr virus (EBV) and Varicella zoster virus (VZV) reactivation was measured in 
saliva, and Cytomegalovirus (CMV) was measured in urine.  Higher levels of salivary EBV 
were found in during the flight-phase than before and after the flight. VZV was detected in 
about 50 % of the astronauts during and up to 5 
days after space flight. No VZV was found in 
any preflight or control samples.  There was 
also no CMV detected in any of the urine 
samples collected pre-flight from astronauts, 
however CMV was shed in 35 % the inflight 
samples and 30% of postflight urine samples of 
the crewmembers.  The in-flight viral 
reactivation data may be summarized as 
follows: EBV (14/17 crewmembers), VZV (7/17 
crewmembers) and CMV (8/17 crewmembers) 
occurred during flight.  
 
 
Physiological Stress:  Stress hormones were measured in plasma, urine and saliva before, 
during and after the spaceflight. There was generally a higher level of cortisol as measured in 
blood, urine and saliva in the astronauts during flight. Circadian rhythm of salivary cortisol was 
normal before and after flight in most of the astronauts, however, changes were observed 
during the flight phase.  
 
Conclusion:  Immune dysregulation, consisting of altered leukocyte distribution, diminished T 
cell function, and altered cytokine production profiles occurs during short duration spaceflight.  
This is accompanied by increases in the reactivation of latent herpesviruses.   For some 
individual crewmembers, correlation may be observed between redistribution of CD8+ T cells, 
T cell function and latent virus reactivation.  This is now defined as a legitimate in-flight 
condition, distinct from the stress of landing and readaptation.   If this phenomenon were found 
to persist for the duration of exploration-class missions, it may represent specific clinical risks 
to crewmembers.   These risks could include persistent infections due to reduced T cell 
function and altered bacterial virulence, hypersensitivities or autoimmunity due to persistent 
Th2 cytokine shifts, the consequences of persistent VZV reactivation (potentially shingles), and 
malignancies due to reduced NK cell function or persistent EBV reactivation.   In such case, 
immune countermeasures development would be necessary to mitigate this risk. 
 
 
 
 
